Biophan Technologies' to Participate at Milken Institute Global Conference.Business Editors/Health/Medical Writers BIOWIRE2K WEST HENRIETTA, N.Y.--(BUSINESS WIRE)--April 26, 2004 Attendees at April 26th Beverly Hills Beverly Hills, city (1990 pop. 31,971), Los Angeles co., S Calif., completely surrounded by the city of Los Angeles; inc. 1914. The largely residential city is home to many motion-picture and television personalities. Conference Include Veritable "Who's-Who" of Investors, Government Leaders and Nobel Laureates Winners of the Nobel Prize are scientists, writers and peacemakers who have been awarded in their field of endeavour, and who are known collectively as either Nobel laureates or Nobel Prize winners. Biophan Technologies, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: BIPH BIPH Bogomoletz Institute of Physiology (National Academy of Sciences; Ukraine) ), an innovator, developer and marketer of advanced biomedical technology, announced today that its CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Michael Weiner, will be participating in the Milken Institute Global Conference in Beverly Hills, California Monday, April 26th through the 28th. The conference is expected to have approximately 1,600 attendees, including multinational leaders in business, finance, government, healthcare and academia, as well as more than 100 leading CEOs. "This conference is a showcase for some of the most influential business leaders in America and we are proud to participate," stated Mr. Weiner. "We have been uncompromising in our mission of educating the institutional and retail community about Biophan's achievement of its strategic initiatives. We believe it is important that the investment community understand the depth of our commitment to our highly articulated strategic plan of aggressively growing our intellectual property portfolio and solutions for improving medical devices. We hope to further cultivate relationships that will lead to greater awareness, understanding, and ultimately use, of Biophan's innovative technologies." About the Institute The Milken Institute is a nonprofit, independent economic think tank whose mission is to improve the lives and economic conditions of diverse populations around the world by helping business and public policy leaders identify and implement innovative ideas for creating broad-based prosperity. It is based in Santa Monica, CA. (www.milkeninstitute.org) (View Conference Agenda at http://www.milkeninstitute.org/events/events.taf?function=show&ID=128& cat=allconf&EventID=GC04&level1=program.) (Due to the length of this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. , it may be necessary to copy and paste To copy files from one location to another or to copy text and images from one document to another. All modern operating systems and applications have a copy and paste capability that is typically selected from an Edit menu. See cut and paste and Win Copy between windows. it into your Internet browser's URL address field. You may also need to remove an extra space in the URL if one exists.) About Biophan Technologies Biophan Technologies develops and markets cutting-edge technologies designed to make biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. (MRI 1. (application) MRI - Magnetic Resonance Imaging. 2. MRI - Measurement Requirements and Interface. ) equipment. The technology is also designed to create enhanced MRI contrast agents. Biophan's goal is to develop and implement technology that will one day make all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com. Cautionary Statement This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risks that could cause actual performance and results of operations to differ materially from those anticipated by these statements. These risks and uncertainties include issues related to the ability to: obtain sufficient funding to continue operations, maintain adequate cash flow, profitably exploit new opportunities, and the unpredictable nature of business risks; as well as other factors set forth in the Company's most recently filed Form 10 reports. The forward-looking statements contained herein represent the Company's judgment as of the date of this release and it cautions readers not to place undue reliance on such statements. The Company assumes no obligation to update the statements contained in this release. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion